CAS 1607819-68-0

TTC-352-13C6

Produto Controlado

CAS: 1607819-68-0

Fórmula: C₁₄₁₃C₆H₁₃FO₃S

Cor e Forma: Neat

Peso molecular: 358.33

Ref: TR-T895602

TTC-352-d4

Produto Controlado

CAS: 1607819-68-0

Fórmula: C₂₀D₄H₉FO₃S

Cor e Forma: Neat

Peso molecular: 356.404

Ref: TR-T895603

TTC-352

Produto Controlado

CAS: 1607819-68-0

Fórmula: C₂₀H₁₃FO₃S

Cor e Forma: Neat

Peso molecular: 352.379

Ref: TR-T895600

TTC-352

CAS: 1607819-68-0

TTC-352 is a small molecule that selectively modulates the activity of certain ion channels. It is an inhibitor of the Kv1.3 channel, which is expressed in neurons and dorsal root ganglion cells. TTC-352 has been shown to inhibit neuronal activity and to be an effective analgesic when used in combination with morphine. TTC-352 has also been shown to have anticancer properties as an inhibitor of epidermal growth factor receptor (EGFR) signaling and as a potential treatment for metastatic melanoma. The ligand binds to the receptor, preventing it from binding to its natural ligands, inhibiting downstream signaling pathways. This inhibition leads to cell death by apoptosis or necrosis depending on the type of cancer cell.

Fórmula: C₂₀H₁₃FO₃S

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 352.40 g/mol

Ref: 3D-HPC81968

TTC-352

CAS: 1607819-68-0

TTC-352 is an oral selective ERalpha partial agonist with potential anti-cancer effects, disrupting ER signaling and tumor cell growth.

Fórmula: C₂₀H₁₃FO₃S

Cor e Forma: Solid

Peso molecular: 352.38

Ref: TM-T70399